CS5001 is so far the first anti-ROR1ADC known to show clinical anti-tumor activity in both solid tumors and lymphomas. The data presented at ASH highlighted the latest safety and efficacy of CS5001 as
80% of surveyed investors said the Challenge enhances trading skills JERSEY CITY,N.J.,Dec. 9,2024-- Leading global investment and trading platformmoomoo proudly announced the successful conclusion of
ARTUSH,China,Dec. 9,2024-- Recently,in order to ensure the safety and reliability of enterprise electricity during the season,the State GridKizilsu Kirghiz Autonomous Prefecture Electric Power Supply
BAZHOU,China,Dec. 9,2024-- Can seafood be farmed in the desert? On December 5th,employees from the State GridBazhou Power Supply Company in Xinjiang visited the Shishixian Aquatic Products Co.,Ltd. se
BEIJING,Dec. 9,2024-- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"),a leading player in mainland China\'s online social networking space,today announced its unau
- OCT Marks Breakthrough in Disease Detection and Manufacturing - TOKYO,Dec. 9,2024-- The Honda Foundation in Tokyo held the 45th Honda Prize Award Ceremony on November 18,2024,where this year\'s priz
